Mark Bonyhadi
16Patents
9h-index
28Co-inventors
72Inventor score
Filing activity: Aug 19, 1993 → Dec 16, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6797514B2 | Simultaneous stimulation and concentration of cells | Chemistry; Metallurgy | 366 | Expired |
| US6905874B2 | Simultaneous stimulation and concentration of cells | Chemistry; Metallurgy | 333 | Expired |
| US6867041B2 | Simultaneous stimulation and concentration of cells | Chemistry; Metallurgy | 329 | Expired |
| US7572631B2 | Activation and expansion of T cells | Chemistry; Metallurgy | 101 | Expired |
| US7977095B2 | Generation and isolation of antigen-specific T cells | Chemistry; Metallurgy | 42 | Active |
| US8617884B2 | Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation | Emerging Cross-Sectional Technologies | 26 | Active |
| US9528088B2 | Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation | Emerging Cross-Sectional Technologies | 24 | Active |
| US11400115B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 11 | Active |
| US7541184B2 | Activation and expansion of cells | Chemistry; Metallurgy | 9 | Expired |
| US5612018A | Drug screening and treatment for HIV thymocyte depletion | Chemistry; Metallurgy | 5 | Expired |
| US5601975A | Method for screening potential therapeutically effective antiviral agents | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5645982A | Method for screening potential therapeutically effective antiviral agents | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12208137B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12258580B2 | Process for generating therapeutic compositions of engineered cells | Chemistry; Metallurgy | 0 | Active |
| US11821027B2 | Epigenetic analysis of cell therapy and related methods | Chemistry; Metallurgy | 0 | Active |
| US12296010B2 | Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.